Insulin resistance and endometrial cancer risk: A systematic review and meta-analysis

European Journal of Cancer

Volumn 51, Issue 18, 2015, Pages 2747-2758

  Hernandez, Adrian V ^a,b   Pasupuleti, Vinay ^c   Benites Zapata, Vicente A ^d   Thota, Priyaleela ^c   Deshpande, Abhishek ^b   Perez Lopez, Faustino R ^e  

^a UNIVERSIDAD PERUANA DE CIENCIAS APLICADAS   (Peru)

^b LERNER RESEARCH INSTITUTE   (United States)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSIDAD DE SAN MARTÍN DE PORRES   (Peru)

^e UNIVERSITY OF ZARAGOZA   (Spain)

Author keywords

Endometrial cancer; Insulin resistance; Meta analysis

Indexed keywords

C PEPTIDE; INSULIN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

CANCER RISK; DIET RESTRICTION; DISEASE ASSOCIATION; EMBASE; ENDOMETRIUM CANCER; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MEDLINE; META ANALYSIS; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; REVIEW; SCOPUS; SYSTEMATIC REVIEW; WEB OF SCIENCE; ADULT; AGED; BLOOD; CHI SQUARE DISTRIBUTION; ENDOMETRIAL NEOPLASMS; FEMALE; GLUCOSE BLOOD LEVEL; LIFESTYLE; METABOLISM; MIDDLE AGED; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION;

ADULT; AGED; BIOMARKERS; BLOOD GLUCOSE; C-PEPTIDE; CHI-SQUARE DISTRIBUTION; ENDOMETRIAL NEOPLASMS; FASTING; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIFE STYLE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; RISK REDUCTION BEHAVIOR;

EID: 84959494983     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2015.08.031     Document Type: Review

References (79)

1. K. Ashihara, T. Tanaka, R. Maruoka, Y.J. Ono, A. Tanabe, Y. Terai, and et al. Postmenopausal patients with endometrial cancer of type 1 have elevated serum estradiol levels in the ovarian vein Int J Gynecol Cancer 24 2014 1455 1460
2. C. Sénechal, E. Cottereau, A. de Pauw, C. Elan, I. Dagousset, V. Fourchotte, and et al. Environmental and genetic risk factors for endometrial carcinoma Bull Cancer 102 2015 256 269
3. K.A. Ashton, A. Proietto, G. Otton, I. Symonds, M. McEvoy, J. Attia, and et al. Polymorphisms in genes of the steroid hormone biosynthesis and metabolism pathways and endometrial cancer risk Cancer Epidemiol 34 2010 328 337
4. J. Xu, X. Lin, H. Zhu, Z. Zhang, and B. Yang Genetic variation of the CYP17 and susceptibility to endometrial cancer: a meta-analysis Mol Biol Rep 40 2013 5085 5091
5. Collaborative Group on Epidemiological Studies on Endometrial Cancer Endometrial cancer and oral contraceptives: an individual participant meta-analysis of 276 women with endometrial cancer from 36 epidemiological studies Lancet Oncol 2015 Aug 4 pii: S1470-2045(15)00212-0. doi:10.1016/S1470-2045(15)00212-0. PubMed PMID: 26254030
6. B. Trabert, N. Wentzensen, H.P. Yang, M.E. Sherman, A.R. Hollenbeck, Y. Park, and et al. Is estrogen plus progestin menopausal hormone therapy safe with respect to endometrial cancer risk? Int J Cancer 132 2013 417 426
7. M. Al-Mubarak, A. Tibau, A.J. Templeton, D.W. Cescon, A. Ocana, B. Seruga, and et al. Extended adjuvant tamoxifen for early breast cancer: a meta-analysis PLoS One 9 2014 e88238
8. L.A. Brinton, C.L. Westhoff, B. Scoccia, E.J. Lamb, B. Trabert, S. Niwa, and et al. Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort Hum Reprod 28 2013 2813 2821
9. K. Bhaskaran, I. Douglas, H. Forbes, I. dos-Santos-Silva, D.A. Leon, and L. Smeeth Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5·24 million UK adults Lancet 384 2014 755 765
10. Y. Zhang, H. Liu, S. Yang, J. Zhang, L. Qian, and X. Chen Overweight, obesity and endometrial cancer risk: results from a systematic review and meta-analysis Int J Biol Markers 29 2014 e21 e29
11. X. Li, and R. Shao PCOS and obesity: insulin resistance might be a common etiology for the development of type I endometrial carcinoma Am J Cancer Res 4 2014 73 79
12. D. Schmid, and M.F. Leitzmann Television viewing and time spent sedentary in relation to cancer risk: a meta-analysis J Natl Cancer Inst 106 2014 pii:dju098
13. C. Liao, D. Zhang, C. Mungo, D.A. Tompkins, and A.M. Zeidan Is diabetes mellitus associated with increased incidence and disease-specific mortality in endometrial cancer? A systematic review and meta-analysis of cohort studies Gynecol Oncol 135 2014 163 171
14. J.A. Barry, M.M. Azizia, and P.J. Hardiman Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod Update 20 2014 748 758
15. T. Wang, T.E. Rohan, M.J. Gunter, X. Xue, J. Wactawski-Wende, S.N. Rajpathak, and et al. A prospective study of inflammation markers and endometrial cancer risk in postmenopausal hormone nonusers Cancer Epidemiol Biomarkers Prev 20 2011 971 977
16. V. Izadi, E. Farabad, and L. Azadbakht Serum adiponectin level and different kinds of cancer: a review of recent evidence ISRN Oncol 2012 2012 982769
17. Q. Zhang, J. Celestino, R. Schmandt, A.S. McCampbell, D.L. Urbauer, L.A. Meyer, and et al. Chemopreventive effects of metformin on obesity-associated endometrial proliferation Am J Obstet Gynecol 209 2013 24.e1-12
18. J.K. Burzawa, K.M. Schmeler, P.T. Soliman, L.A. Meyer, M.W. Bevers, T.L. Pustilnik, and et al. Prospective evaluation of insulin resistance among endometrial cancer patients Am J Obstet Gynecol 204 2011 355.e1-7
19. M.J. Gunter, D.R. Hoover, H. Yu, S. Wassertheil-Smoller, J.E. Manson, J. Li, and et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer Cancer Epidemiol Biomarkers Prev 17 2008 921 929
20. F.R. Pérez-López Metformine treatment and evolution of endometrial cancer Climacteric 17 2014 207 209
21. D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, and R.C. Turner Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man Diabetologia 28 1985 412 419
22. G.A. Wells, B. Shea, D. O'Connell, J. Peterson, V. Welch, M. Losos, and et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses 2011 Ottawa Health Research Institute Ottawa, Canada Available http://www.ohri.ca/programs/clinical-epidemiology/oxford.htm
23. R. Herzog, M.J. Álvarez-Pasquin, C. Díaz, J.L. Del Barrio, J.M. Estrada, and Á. Gil Are healthcare workers' intentions to vaccinate related to their knowledge, beliefs and attitudes? A systematic review BMC Public Health 13 2013 154
24. D. Moher, A. Liberati, J. Tetzlaff, and D.G. Altman PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement J Clin Epidemiol 62 2009 1006 1012
25. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control Clin Trials 7 1986 177 188
26. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
27. J.P. Higgins Commentary: heterogeneity in meta-analysis should be expected and appropriately quantified Int J Epidemiol 37 2008 1158 1160
28. M. Egger, G. Davey Smith, M. Schneider, and C. Minder Bias in meta-analysis detected by a simple, graphical test BMJ 315 1997 629 634
29. J.M. Cheng, A. Corstiaan, S.E. Hoeks, M. van der Ent, L.S. Jewbali, R.T. van Domburg, and et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials Eur Heart J 30 2009 2102 2108
30. S.P. Hozo, B. Djulbegovic, and I. Hozo Estimating the mean and variance from the median, range, and the size of a sample BMC Med Res Methodol 5 2005 13
31. H. Guo, W. Ling, Q. Wang, C. Liu, Y. Hu, M. Xia, and et al. Effect of anthocyanin-rich extract from black rice (Oryza sativa L. indica) on hyperlipidemia and insulin resistance in fructose-fed rats Plant Foods Hum Nutr 62 2007 1 6
32. C. Battaglia, F. Mancini, A. Cianciosi, P. Busacchi, F. Facchinetti, G.R. Marchesini, and et al. Vascular risk in young women with polycystic ovary and polycystic ovary syndrome Obstet Gynecol 111 2008 385 395
33. Review Manager (RevMan) [Computer program]. Version 5.1 2011 The Nordic Cochrane Centre, The Cochrane Collaboration Copenhagen
34. W.E. Lucas, and S.S.C. Yen A study of endocrine and metabolic variables in postmenopausal women with endometrial carcinoma Am J Obstet Gynecol 134 1979 180 185
35. K.E. Anderson, E. Anderson, P.J. Mink, C.P. Hong, L.H. Kushi, T.A. Sellers, and et al. Diabetes and endometrial cancer in the Iowas Womeńs Health Study Cancer Epidemiol Biomarkers Prev 10 2001 611 616
36. L. Dossus, A. Lukanova, S. Rinaldi, N. Allen, A.E. Cust, S. Becker, and et al. Hormonal, metabolic, and inflammatory profiles and endometrial cancer risk within the EPIC cohort - A factor analysis Am J Epidemiol 177 2013 787 799
37. M. Nagamani, C.A. Stuart, P.A. Dunhardt, and M.G. Doherty Specific binding sites for insulin and insulin-like growth factor I in human endometrial cancer Am J Obstet Gynecol 165 1991 1865 1871
38. E.M. Rutanen, S. Stenman, W. Blum, T. Karkkainen, P. Lehtovirta, and U.H. Stenman Relationship between carbohydrate metabolism and serum insulin-like growth factor system in postmenopausal women: comparison of endometrial cancer patients with healthy controls J Clin Endocrinol Metab 77 1993 199 204
39. V.B. Gamayunova, Y.F. Bobrov, E.V. Tsyrlina, T.P. Evtushenko, and L.M. Berstein Comparative study of blood insulin levels in breast and endometrial cancer patients Neoplasma 44 1997 123 126
40. R. Troisi, N. Potischman, R.N. Hoover, P. Siiteri, and L.A. Brinton Insulin and endometrial cancer Am J Epidemiol 146 1997 476 482
41. B. Waksmański, J. Dudkiewicz, and S. Dabrowski Function of insulin-like growth factor (IGF-I) and its binding protein (IGFBP-1) in pathological proliferation of endometrium Wiad Lek 54 2001 656 661
42. E. Weiderpass, K. Brismar, R. Bellocco, H. Vainio, and R. Kaaks Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk Br J Cancer 89 2003 1697 1704
43. A. Lukanova, A. Zeleniuch-Jacquotte, E. Lundin, A. Micheli, A.A. Arslan, S. Rinaldi, and et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer Int J Cancer 108 2004 262 268
44. A.E. Cust, N.E. Allen, S. Rinaldi, L. Dossus, C. Friedenreich, A. Olsen, and et al. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition Int J Cancer 120 2007 2656 2664
45. S.F. Hua, F.X. Xue, L.Z. Zhang, and J. Zhao Expression and activation of insulin receptor substrate-1 in endometrial carcinoma Chin J Obstet Gynecol 43 2008 437 441
46. C.M. Friedenreich, R.K. Biel, D.C. Lau, I. Csizmadi, K.S. Courneya, A.M. Magliocco, and et al. Case-control study of the metabolic syndrome and metabolic risk factors for endometrial cancer Cancer Epidemiol Biomarkers Prev 20 2011 2384 2395
47. C.M. Friedenreich, A.R. Langley, T.P. Speidel, D.C. Lau, K.S. Courneya, I. Csizmadi, and et al. Case-control study of markers of insulin resistance and endometrial cancer risk Endocr Relat Cancer 19 2012 785 792
48. S.C. Modesitt, D.L. Geffel, J. Via, and A. L Weltman Morbidly obese women with and without endometrial cancer: are there differences in measured physical fitness, body composition, or hormones? Gynecol Oncol 124 2012 431 436
49. J.R. Fu, L.N. Lu, L.P. Yu, D.Y. Wang, and K.S. Ding Serum changes of adiponectin, insulin resistance and their correlation in endometrial cancer patients Chin J Obstet Gynecol 47 2012 672 675
50. C.M. Dallal, L.A. Brinton, D.C. Bauer, D.S. Buist, J.A. Cauley, T.F. Hue, and et al. B∼FIT Research Group. Obesity-related hormones and endometrial cancer among postmenopausal women: a nested case-control study within the B∼FIT cohort Endocr Relat Cancer 20 2013 151 160
51. Y. Ma, Z. Liu, Y. Zhang, and B. Lu Serum leptin, adiponectin and endometrial cancer risk in Chinese women J Gynecol Oncol 24 2013 336 341
52. Y. Zhan, J. Wang, Y. Ma, Z. Liu, H. Xu, S. Lu, and et al. Serum insulin-like, growth factor binding protein-related protein 1 (IGFBP-rP1) and endometrial cancer risk in Chinese women Int J Cancer 132 2013 411 416
53. S.O. Altinkaya, S. Nergiz, M. Küçük, and H. Yüksel Apelin levels are higher in obese patients with endometrial cancer J Obstet Gynaecol Res 41 2015 294 300
54. G.S.R. Kedari Evaluation of hyperinsulinemia, inflammation and lipid profile in patients with endometrial cancer Int J Pharm Bio Sci 5 2014 238 244
55. S. Erdogan, S. Sezer, E. Baser, O. Gun-Eryilmaz, T. Gungor, S. Uysal, and et al. Evaluating vaspin and adiponectin in postmenopausal women with endometrial cancer Endocr Relat Cancer 20 2013 669 675
56. W. Shan, C. Ning, X. Luo, Q. Zhou, C. Gu, Z. Zhang, and et al. Hyperinsulinemia is associated with endometrial hyperplasia and disordered proliferative endometrium: a prospective cross-sectional study Gynecol Oncol 132 2014 606 610
57. E.A. Bishop, S. Lightfoot, E. Thavathiru, and D.M. Benbrook Insulin exerts direct effects on carcinogenic transformation of human endometrial organotypic cultures Cancer Invest 32 2014 63 70
58. K. Esposito, P. Chiodini, A. Capuano, G. Bellastella, M.I. Maiorino, and D. Giugliano Metabolic syndrome and endometrial cancer: a meta-analysis Endocrine 45 2014 28 36
59. B. Arcidiacono, S. Iiritano, A. Nocera, K. Possidente, M.T. Nevolo, V. Ventura, and et al. Insulin resistance and cancer risk: an overview of the pathogenetic mechanisms Exp Diabetes Res 2012 2012 789174
60. M. Zhang, X. Li, X. Zhang, Y. Yang, Z. Feng, and X. Liu Association of serum hemoglobin A1c, C-peptide and insulin-like growth factor-1 levels with the occurrence and development of lung cancer Mol Clin Oncol 2 2014 506 508
61. E. Melles, H. Jornvall, S. Tryggvason, K.G. Danielsson, K. Ekberg, K. Tryggvason, and et al. Degradation of proinsulin C-peptide in kidney and placenta extracts by a specific endoprotease activity Cell Mol Life Sci 61 2004 2979 2982
62. A. Tura, B. Ludvik, J.J. Nolan, G. Pacini, and K. Thomaseth Insulin and C-peptide secretion and kinetics in humans: direct and model-based measurements during OGTT Am J Physiol Endocrinol Metab 281 2001 E966 E974
63. C.M. Kitahara, B. Trabert, H.A. Katki, A.K. Chaturvedi, T.J. Kemp, L.A. Pinto, and et al. Body mass index, physical activity, and serum markers of inflammation, immunity, and insulin resistance Cancer Epidemiol Biomarkers Prev 23 2014 2840 2849
64. B. Singh, and A. Saxena Surrogate markers of insulin resistance: a review World J Diabetes 1 2010 36 47
65. R. Murali, R.A. Soslow, and B. Weigelt Classification of endometrial carcinoma: more than two types Lancet Oncol 15 2014 e268 e278
66. V.W. Setiawan, H.P. Yang, M.C. Pike, S.E. McCann, H. Yu, Y.B. Xiang, and et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 31 2013 2607 2618
67. S.K. Garg, H. Maurer, K. Reed, and R. Selagamsetty Diabetes and cancer: two diseases with obesity as a common risk factor Diabetes Obes Metab 16 2014 97 110
68. R.E. Schmandt, D.A. Iglesias, N.N. Co, and K.H. Lu Understanding obesity and endometrial cancer risk: opportunities for prevention Am J Obstet Gynecol 205 2011 518 525
69. V. Rosato, A. Zucchetto, C. Bosetti, L. Dal Maso, M. Montella, C. Pelucchi, and et al. Metabolic syndrome and endometrial cancer risk Ann Oncol 22 2011 884 889
70. R. Simó, C. Saez-Lopez, A. Lecube, C. Hernandez, J.M. Fort, and D.M. Selva Adiponectin upregulates SHBG production: molecular mechanisms and potential implications Endocrinology 155 2014 2820 2830
71. R. Simó, C. Sáez-López, A. Barbosa-Desongles, C. Hernández, and D.M. Selva Novel insights in SHBG regulation and clinical implications Trends Endocrinol Metab 26 2015 376 383
72. N. Mu, Y. Zhu, Y. Wang, H. Zhang, and F. Xue Insulin resistance: a significant risk factor of endometrial cancer Gynecol Oncol 125 2012 751 757
73. E. Giovannucci, D.M. Harlan, M.C. Archer, R.M. Bergenstal, S.M. Gapstur, L.A. Habel, and et al. Diabetes and cancer: a consensus report CA Cancer J Clin 60 2010 207 221
74. V. Gristina, M.G. Cupri, M. Torchio, C. Mezzogori, L. Cacciabue, and M. Danova Diabetes and cancer: A critical appraisal of the pathogenetic and therapeutic links Biomed Rep 3 2015 131 136
75. N.E. Allen, T.J. Key, L. Dossus, S. Rinaldi, A. Cust, A. Lukanova, and et al. Endogenous sex hormones and endometrial cancer risk in women in the European Prospective Investigation into Cancer and Nutrition (EPIC) Endocr Relat Cancer 15 2008 485 497
76. D. Aune, D.A. Navarro Rosenblatt, D.S. Chan, S. Vingeliene, L. Abar, A.R. Vieira, and et al. Anthropometric factors and endometrial cancer risk: a systematic review and dose-response meta-analysis of prospective studies Ann Oncol 26 2015 1635 1648
77. D.H. Cohen, and D. LeRoith Obesity, type 2 diabetes, and cancer: the insulin and IGF connection Endocr Relat Cancer 19 2012 F27 45
78. S.L. Doyle, C.L. Donohoe, J. Lysaght, and J.V. Reynolds Visceral obesity, metabolic syndrome, insulin resistance and cancer Proc Nutr Soc 71 2012 181 189
79. R. Simó, A. Barbosa-Desongles, A. Lecube, C. Hernandez, and D.M. Selva Potential role of tumor necrosis factor-α in downregulating sex hormone-binding globulin Diabetes 61 2012 372 382